Epigenetics and depression : a rabbit hole of discovery by Pace, Raquel & Blundell, Renald
Open Journal of Genetics, 2018, 8, 67-90 
http://www.scirp.org/journal/ojgen 
ISSN Online: 2162-4461 




Epigenetics and Depression: A Rabbit Hole of 
Discovery 
Raquel Pace, Renald Blundell 





“After this, there is no turning back. You take the blue pill—the story ends, 
you wake up in your bed and believe whatever you want to believe. You take 
the red pill—you stay in Wonderland, and I show you how deep the rabbit 
hole goes. Remember: all I’m offering is the truth.” Epigenetics is a bit like the 
red pill—the more it is researched the further down the rabbit hole we are 
going—the realisation that my choices today as my parents’ and grandpar-
ents’ choices yesterday influence who I am now and who I am going to be 
tomorrow. Through the study of gene influencers, scientists are discovering 
that it is not only the DNA that makes us but which portion of is selected for 
use that tells us who we are. In the field of depression, epigenetics is still in its 
infancy, nonetheless significant connections have been uncovered. This paper 
gives a brief overview on epigenetics and the different mechanisms correlated 
with it. It also discusses factors affecting an individual’s epigenetic patterns 
and the effect of epigenetics itself. It specifically delves into the epigenetic ef-
fects on psychiatry, mainly depression, depressive symptoms and antidepres-
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1. What Is Epigenetics? 
1.1. A Basic Overview 
Not everything that is inherited is genetic. Along with the genes, chemical 
markers found on the genes undergo duplication when DNA is replicated [1]. 
Epigenetics is the variations in gene expression which aren’t a result of DNA 
How to cite this paper: Pace, R. and Blun-
dell, R. (2018) Epigenetics and Depression: 
A Rabbit Hole of Discovery. Open Journal 
of Genetics, 8, 67-90. 
https://doi.org/10.4236/ojgen.2018.83007 
 
Received: July 10, 2018 
Accepted: September 27, 2018 
Published: September 30, 2018 
 
Copyright © 2018 by authors and  
Scientific Research Publishing Inc. 
This work is licensed under the Creative 
Commons Attribution International  
License (CC BY 4.0). 




DOI: 10.4236/ojgen.2018.83007  Sep. 30, 2018 67 Open Journal of Genetics 
 
R. Pace, R. Blundell 
 
sequence modification. It is mainly characterised by histone tail modification or 
DNA methylation. In general, this means that “tags” or “tails” are added to the 
DNA in order to switch on or switch off certain genes (in the case of methyla-
tion) and to enhance or diminish activity of certain genes (in the case of histone 
modification). The epigenetic changes can be inheritable or environmental in 
nature and refer to changes which are in themselves reversible in nature. The 
epigenetic effects may give rise to phenotypical differentiated cells and tissues 
within an organism [2] [3]. 
Epigenetics is a cornerstone in evolution and aids in determining the success 
of a species. A prosperous population is one that can juggle a consistency in 
phenotype when presented with a stable surrounding environment and an ability 
to change phenotype as a reaction to a drastic environmental shift. Phenotypical 
changes can dually result: directly, from a change in the genome itself by steady 
physical changes in DNA sequence which would ultimately lead to mutations; 
and indirectly, as reversible chemical alterations in nucleotides or chromatin 
structure ultimately leading to epi-mutations [4]. 
Epigenetics is a wide term that mainly encompasses inherited and environ-
mental factors which give rise to the various mechanisms of DNA expression 
regulation [5].  
1.2. Chromatin, Histones and Remodelling 
Proper functionality of a eukaryotic cell requires the compression of the long 
DNA strand into a minute nucleus. A 2-metre-long strand has to squeeze into a 
5-micrometre space and in doing so the strand still has to be adequately accessi-
ble and unwindable to allow for replication, transcription and DNA repair— 
necessary functions for development and tissue-specific roles. Histones bring 
about the compression of chromatin. DNA is negatively charged and histones 
are positively charged, the opposing charges create a strong adherence of DNA 
to histone octamer in the formation of nucleosomes. In between each nu-
cleosome H1 prompts further compacting into a chromatin fibre. Further coiling 
would result in euchromatin and then heterochromatin. This is seen depicted in 
the following diagram (Figure 1) [6] [7]. 
Modifications of DNA alter its structure. This is done by the changing of 
physical properties of individual nucleosomes chiefly through the addition or 
removal of charges from or to the target proteins or nucleic acids. The commu-
nication between charge of residues and the structure of chromatin is more often 
than not indirect. The state of chromatin in most scenarios depends on the 
complex interactions of the alterations of the vast amount of specialised nuclear 
proteins. 
The structure of the chromatin is controlled and differentiated by a variety of 
processes: 
o DNA methylation—nucleotide covalent alteration in which a methyl group is 
either added to a cytosine residue at position C-5 or N-4, or to an adenine 
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residue at position N-6 [8]. 
o ATP-dependent remodelling of nucleosome cores—utilising the energy from 
ATP hydrolysis to form, disturb or relocate nucleosomes by altering His-
tone—DNA interactions [9]. 
o Covalent modifications of histone tails—histone acetyltransferase, HAT, and 
histone deacetylase, HDAC, complexes, activate and repress transcription of 
genes respectively by determining the level of acetylation of the amino-terminal 
domains of nucleosomal histones associated with them [10]. 
o Replacement of core histones by their alternatives—histones synthesis occurs 
mainly at S phase for swift deposition after replication forks to fill in open-
ings resulting from the dispersal of pre-existing histones. In addition, the re-
placement of established S-phase histones by variants, independent of repli-
cation, can possibly differentiate chromatin. “The replacement of a canonical 
histone by a non-canonical variant is a dynamic process that changes the 
composition of chromatin.” [11] 
o Nucleosome eviction—exposes associated DNA through ATP-dependent 
remodelling, specifically a change in the location or composition of nu-
cleosomes in relation to the DNA that is wrapped around it [6]. 
Figure 2 portrays the mechanisms of chromatin structure variation. 
 
 
Figure 1. The role of histones in DNA Packaging [7]. 
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Figure 2. Epigenetic Modifications, repression and activation [12]. 
1.2.1. DNA Methylation 
DNA methylation is one of the oldest mechanisms of gene expression regulation. 
Specifically, the addition or removal (demethylation) of a methyl group affects 
regulation, and the timing and specific sequence area targeted determine the 
timing and occurrence of cellular events. 
A gene is not allowed to transcribe i.e. rendered useless by blocking off the 
start site or near the start site of transcription of that particular gene. The start 
site or promoter region is marked by a cytosine followed immediately by a gua-
nine reading in the 5’  3’ direction. They are separated only by a phosphate 
and therefore the site is aptly referred to as a CpG site—cytosine, phosphate, 
guanine [3]. 
Methylation occurs symmetrically at the CpG site, meaning that both DNA 
strands carry the marker. GC (guanine—cytosine) content in the human genome 
is around 42%, therefore, if the numbers were to follow the ratios seen in other 
animal models CpG sites would be at 4.41%. However, they are represented at a 
frequency of less than 1%. Conversely, the CpG sites are more commonly found 
in clusters referred to as CpG islands which are constituted by 50% of GC with 
an observed is to expected occurrence of CpG higher than 0.6 in the length of 
200 nt (nucleotides). Even though, only about 10% of all the cytosines in a ge-
nome are methylated, CpG islands play a crucial in transcriptional silencing [8] 
[13] [14]. 
DNA methylation patterns are brought about by: 
o A family of de novo methyltransferases (DNMT); 
• DNA methyltransferase 3 (DNMT3); 
• And upheld by DNMT1 (the maintenance methyltransferase). 
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In general, DNMTs are three-dimensional proteins with motifs I-X located in 
the carboxyl end of the structure. The motifs have a specific function, as listed 
below: 
o I and X form the SAM binding site; 
o IV has a prolylcysteinyl dipeptide providing the thiolate at the active site 
which mediates the exchange of a methyl group from the SAM onto the cyto-
sine; 
o Between VIII and IX one can find the target recognition domain; 
o VI protonates N3 points of the targeted cytosine by a glutamyl residue. 
There are three big families of DNMTs; DNMT1, 2 and 3. The 1 and 3 families 
have members with definite function at CpG sites and islands, whereas DNMT2 
is lowly expressed within all tissues and has an undetectable activity. Nonethe-
less, its activity seems to be present in vitro and it can catalyse RNA methylation 
[15]. 
There are 2 occurrences of de novo DNA methylation at the developmental 
stage of an embryo after demethylation episodes have taken place which erase 
the imprints established by the former generation. One occurs as early as right 
after embryonic implantation and affects the cells of the embryoblast. This epi-
genetically differentiates the embryoblast from the trophoectoderm. The 2nd oc-
curs in primordial germ cells (PGCs) after implantation. In females, methylation 
levels in PGCs drops by 70% and takes place at oocyte growth phase postnatally 
while in males, levels drop by 60%, taking place just a few days after the 1st de 
novo reprogramming. The image below (Figure 3) gives an overview on the 
process of DNA methylation and histone modification mechanisms [8]. 
1.2.2. Abnormal DNA Methylation 
One of the main functions of DNA methylation is to control the compartmen-
talisation of DNA. This guarantees the replication of specific sequences of tran-
scriptionally active chromatin before the remaining transcriptionally inactive 
chromatin. Imbalance in the DNA methylation within cells can cause extensive 
hypomethylation, local hypermethylation and increase the cell’s methylation ca-
pacity. Hyper- and hypo-methylation seem to affect different DNA sequences 
and it is apparent that much more of the genome is subject to hypo- than hy-
per-methylation.  
Less or more methylation is relative. It is usually determined through com-
parison with a standard. The standard typically refers to normal tissue cells. 
Nonetheless, a great deal of variance is found in the quantity and distribution of 
DNA methylation amid different vertebral tissues. This is to say that DNA me-
thylation is not just species-specific but also tissue-specific. In addition, uncul-
tured cells should be taken for study whenever it is made possible as cultured 
cells tend to produce changes in their DNA methylation. Another issue to con-
sider is that populations of pure uncultured cells may differ from each other by 
their genomic methylation content. Hence, unless the abnormally methylated 
cells are compared to a rather pure population of cells which are known to be the  
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Figure 3. DNA methylation and histone acetylation on chromatin structure [16]. 
 
cell origin of the abnormal cells (which is almost never the case), it is always best 
to take an average of the methylation by taking DNA samples from cells across a 
multitude of tissues for the control. 
Abnormal chromatin organisation is marked by, and many times caused by, 
the changed methylation patterns, particularly by regional hypermethylation. 
Following altered chromatin structure, increasing loss of gene expression may 
take place (as in the formation of tumours and other abnormalities) through di-
rect transcriptional inactivation of genes, an increased predilection to mutations 
and deletion of alleles [17] [18]. 
1.2.3. A General Introduction on Imprinting 
Everyone has 2 sets of 23 chromosomes, one from their mother and one from 
their father. Gene expression is usually dependent on whether a gene is auto-
somal dominant or recessive and its counterpart from the other parent.  
Imprinting is a non-pathological process by which DNA expression is altered 
by means of external modifications and not direct DNA mutations. Thus, it is an 
epigenetic route of modulating gene expression. Imprinting is a hereditary in-
fluence that is either a maternal or paternal epigenetic altering factor which per-
tains to the modified gene expression [2] [3]. 
 
DOI: 10.4236/ojgen.2018.83007 72 Open Journal of Genetics 
 
R. Pace, R. Blundell 
 
That is, imprinting will occur depending on whether it is inherited from the 
mother or father, parent of origin dependent methylation of DNA. So, when the 
maternal one is active, the paternal one is silent or vice versa. Hence, only 1 al-
lele (either maternal or paternal) is expressed in the zygote. The “silent” or 
switched off allele is methylated so as rendering it unable to be transcribed. It is 
of crucial importance for mammalian development. Differentially methylated 
regions (DMRs), also known as imprint control regions (ICRs) are DNA methy-
lation instances that occur in an allele-specific manner. Activity of gene in zygote 
depends on whether gene is from the mother or the father. It is a mono-allelic, 
parent-of-origin specific gene methylation and expression [19] [20]. 
In females, only one of the 2 homologous X chromosome is active. Imprinting 
ensures the selective expression of one of the chromosomes by methylation of 
the inactive copy [8]. 
Even though imprinting occurs in a very small portion of the entire genome, it 
contributes greatly to embryogenesis, reproduction and gametogenesis. Defects, 
disorders or relaxation in the imprinting process give a loss of imprinting on loci 
which are dependent on this process. In turn, this gives rise to rare diseases 
which affect growth, development, behaviour and metabolism which are associ-
ated with epigenetic distortion of imprinting genes [2]. 
1.2.4. Histone Modification 
Acetylation and methylation of histones are the commonest types of histone 
modification. Euchromatin, the more active configuration of chromatin, is asso-
ciated with high levels of acetylation and methylation at H3K4, H3K36 and 
H3K79. Conversely, heterochromatin, a much more condensed chromatin, is 
thus more associated with deacetylation and methylation of H3K9, K3K27 and 
H4K20 [8]. 
1) Histone Acetylation/Deacetylation 
Acetylation is brought on by HAT proteins that belong to 3 families; GNAT, 
MYST and CBP/p30. In general, these preferentially target histones H3 and H4 
for acetylation. They are able to acetylate both histone and non-histone proteins. 
Deacetylation occurs through the use of HDAC proteins that are also classified 
into 3 groups; type I, II and III. All 3 types bring about deacetylation of the 
N-terminal tails of histones where the acetylated residues reside, except in 
H3K59—found in core domain [8] [10]. 
2) Histone Methylation/Demethylation 
Methylation is catalysed by histone methyltransferases (histone KMTases). In 
comparison to acetylation, methylation is a more complex type of modification. 
Methylation constitutes of 3 different states; mono-, di- and trimethylation. It 
can mark lysine and arginine and start or stop transcription based on the loca-
tion and number of attached methyl-groups [8] [10]. 
3) Histone Variants 
Histone variants are different from their respective canonical S-phase histones 
in ways that can lead to great chromatin differentiation. There exists the potential 
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of switching a chromatin state by histone replacement. Substituting one histone 
with a variant could also delete or change posttranslational modifications pat-
terns, and therefore, can potentially reset epigenetic states that are thought to be 
mediated by histones and their modifications. 
Histones H2A, H2B, H3, and H4 inhabit distinct locations in the core particle. 
Subsequent changes of the four core histones into distinct variants have pro-
vided the foundation for epigenetic routes, including development and chromo-
some segregation. The active behaviour of chromatin leads to the comprehen-
sion that transcription, chromatin remodelling, and histone modification might 
be combined with nucleosome assembly and disassembly. Histone variants are 
also entangled in particular epigenetic occurrences. For instances, the X chro-
mosome has 3 different H2A variants which have been enlisted to participate in 
silencing or activation of genes for germline inactivation or dosage compensa-
tion [8] [11]. 
4) Other Forms of Histone Modifications 
Less common histone modification mechanism are phosphorylation and 
ubiquitination. Phosphorylation is in control of decondensation of chromatin 
fibres, i.e. allowing for the activation of transcriptional activity but in contrast, 
also allowing for the compaction of chromosomes during cell division. With re-
gards to ubiquitination, through this, histone proteins nearly double in size. 
Histones are usually mono-ubiquitinated. Poly-ubiquitination, much like me-
thylation, gives rise to activation or repression of transcription depending on 
which histone protein undergoes ubiquitination [8]. 
1.3. The Involvement of Non-Coding RNAs in Epigenetic Processes 
Non-coding RNAs (ncRNAs) have a role in transcription silencing, imprinting 
and amending heritable reactions to changes the environmental conditions the 
organism is exposed to. ncRNAs have been found to play major roles in proc-
esses such as cell patterning, differentiation, progression of cell cycle, stability of 
genome and apoptosis. Loss of ncRNAs would lead to downregulation of such 
important processes which can ultimately lead to various human diseases due to 
increased susceptibility. 
Small regulatory RNAs are single stranded ncRNAs derived from comple-
mentary or semi-complementary double-stranded RNA (dsRNA) molecules and 
take part in transcriptional and post-transcriptional gene silencing, PTGS. PTGS 
is the downregulation of expression of the genome after transcription and 
mRNA maturation. Small RNAs are involved in a vast array of different func-
tions in cell biogenesis including: 
o RNA interactions—including with other small RNAs and mRNA 
o Protein binding 
o Direct reversible and irreversible changes to DNA and RNA sequences— 
methylation and genome editing respectively. 
Long ncRNAs (lncRNAs) are less conserved in sequence and structure than 
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small ncRNAs, with some regions in the lncRNAs more conserved than others. 
This indicates towards more important sequences or structure recognition areas. 
lncRNAs transcription is regulated by developmental processes and differentia-
tion. This accompanied with the knowledge that lncRNAs are restricted to cer-
tain compartments in the cell suggest an importance of lncRNAs in certain cel-
lular processes. Such that, changes in their expression have been observed to lead 
to a variety of human diseases. 
Other types of ncRNAs: 
o microRNA (miRNA) 
o small interfering RNA (siRNA) 
o P-element-induced wimpy testes (PIWI)-interacting RNA (piRNA) [8] [21] 
2. Epigenetics and the Environment 
It is apparent that epigenetic alterations modulate molecular, cellular and organ-
ismal reactions to environmental changes. At every point in one’s lifetime they 
are exposed to various physical, chemical and social agents that can have benefi-
cial and detrimental interactions with the individual. A person’s exact exposure 
to the environment, regarding duration, degree and type of environmental agent 
differs greatly from everyone else’s, it is unique and ever changing. 
Examples of environmental factors and their effect on health: 
o Second-hand smoking—exposure is very directly linked to lung cancer de-
velopment, or rather linked to a much higher susceptibility percentage to 
lung cancer development 
o Socioeconomic status—different childhood status is associated with dissimi-
larities in common health indicators, like BMI and blood pressure 
o Dietary content—bioactive food components such as in the agouti mice ex-
periment 
o Radiation exposure—direct/indirect radiation effects in tumour suppression 
inhibition 
Figure 4 gives a concise overview on diverse environmental factors and their 
possible effects on epigenetics. 
Environmental, epigenetics and phenotype and their relations are very clearly 
seen in the agouti locus in mice. The agouti loci are correlated to coat colour, 
obesity and cancer in mice and changes in parental diet so as to have a methyl 
content have proven to foster epigenetic changes in previously mentioned traits 
in offspring. Figure 5, found on the following page, demonstrates the agouti 
methyl-diet experiment [8] [22]. 
Environmental conditions that effect nutritional, physical and emotional 
health of a person can have long-term repercussions on metabolism and affec-
tive states in offspring—probably by action on promoter or enhancer related 
DNA methylation of the relevant genes. 
Adverse environments in early childhood and parental care leave a long-lasting 
imprint on epigenetic regulation of steroid receptors and other genes, like 
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γ-aminobutyric acid (GABA). This is seen through detailed examination of the 
promoter structures of stress-related glucocorticoid receptor genes in humans. 
Evidence shows that along with environmental toxins, diet and environmental 
enrichment might regulate phenotypic variations in following generations via 
germline transmission through the involvement of DNA methylation and his-
tone alteration and small RNAs [24]. 
2.1. A Global Human Contribution—Air Pollution 
Air pollution levels are always on the rise. The health risks (e.g. lung cancer) as-
sociated with it are thus, also on the rise. Examples of an air pollutant is black 
carbon—associated with cardiovascular morbidity and those related to cardio-
vascular disease. Asthma is principally related to air pollution which increases 
asthmatic episodes and susceptibility for onset of asthma. 
 
 
Figure 4. A Flowchart depicting an overview on the effect of the 
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Figure 5. Methyl diet and normal diet differences in agouti mice. The yellow coated, 
obese mice are also predisposed to cancer and diabetes [23]. 
 
Regulatory T cells (Treg) is involved in development and advancement of 
asthma. Its activity may be modified my DNA hypermethylation. A study ex-
amining relations between asthma, air pollution and epigenetics brought credit 
to the notion that air pollution affects DNA methylation which impairs Treg 
function which in turn progress the pathogenesis of asthma [8]. 
2.2. Psychological Environment 
Another environment to consider is the psychological environment. Stress is a 
reaction to threats the organism feels exposed to in an environment. It gives 
both behavioural and psychological stress responses. Stress is nowadays associ-
ated with very negative ideas. However, the purpose of stress is to respond to it 
in a way that makes the individual cautious around dangerous situations and it is 
thus critical for ensuring good health and survival [8] [21]. 
Nevertheless, there is something as too much stress, a state most people are 
too familiar with. Exposure to stress early on in life is closely related to negative 
effects on growth and intellect in conjunction with increased risks of obesity and 
mental illness. Additionally, stress later in life can result in adverse effects as 
well, such as a traumatic experience triggering the development of PTSD [25] 
[26]. 
2.3. The twin Model in Epigenetics 
Monozygous twins, i.e. identical twins, provide an irreplaceable model for study 
of the effect of environmental factors on an organism. In essence, twins start out 
with similar epigenetics. As they grow older differences start to emerge. The 
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more time they spend apart and the more drastic differences there are in their 
respective environments and lifestyles, the greater segregation and differentia-
tion observed in their epigenetics that can affect anything from the appearance 
of wrinkles to the predisposition to diseases [8] [27]. 
3. Epigenetics in Neuroscience 
Research has shown that neurological processes are regulated by epigenetic 
component like DNA methylation, histone modification, chromatin remodelling 
and ncRNAs. Such processes that epigenetics influences include neuron devel-
opment and function, neuronal plasticity and memory formation [8]. 
There is a bountiful amount of information supporting further investigation 
into the epigenetics in neuroscience. This includes the following ideas: 
o Plasticity throughout all brain development and aging of most epigenetic 
markers with continuous and constant regulation in neurones; 
o Therapeutic potential of epigenetics in neurological and psychiatric diseases. 
For example, histone deacetylation inhibition by chromatin-modifying drugs 
which exert great effects on learning, memory and neurodegenerative disor-
ders;  
o Transgenerational epigenetic inheritance—certain behavioural experiences 
during one’s life can consequently be carried on to offspring. Nutrition, emo-
tional and physical health of parent (environmental conditions) may have 
long-term results on the following generation at the same sites as the parent. 
Promoter or enhancer-related sites of the relevant genes on the genome are 
most probably affected epigenetically by methylation modifications [24]. 
3.1. DNA Methylation 
At brain development, DNA methylation has a hand in the regulation of the 
proliferation of neuronal stem cells and their differentiation into glial cells and 
neurons. DNMTs are highly expressed throughout the developmental stage and 
uphold survival and plasticity of the neurons. In addition to DNMTs, 
methyl-CpG binding domains (MBDs) are shown and they also have a role in 
brain development with further activity in cognitive functions like learning and 
memory. DNA methylation has also been found important in adult CNS neu-
rons (for the same functions as previously listed) and not just in the developing 
brain [8]. 
3.2. Histone Modification and Chromatin Structure 
A holistic understanding of histone modification and chromatin structure re-
modelling can provide important insight on how stable gene expression changes 
in the brain can produce long-lasting alterations in behaviour. Neuronal signal-
ling seems to be regulated greatly by histone acetylation/deacetylation and DNA 
methylation/demethylation. 
Formation of long-term memory has seen to depend on chromatin remodel-
ling by post-translational histone protein alteration. Furthermore, disruption in 
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the balance between HDAC and HAT activities can result in neurodegenerative 
diseases. HDAC inhibitors, i.e. blocking the removal of acetylation from the 
N-terminal histone tails, have been proven to show a therapeutic effect on ani-
mal models with neurodegenerative diseases insinuating a neuroprotective role 
[8] [10]. 
3.3. The ncRNAs 
The ncRNAs make up approximately 98% of the transcriptional activity of ge-
nomic DNA. They don’t behave as mRNA, tRNA or rRNA. A particularly 
abundant type of ncRNA in the brain is miRNA. miRNAs have a role in gene 
expression regulation through an RNA interference pathway that alters mRNA 
stability and initiation of translation. One miRNA is capable of regulating thou-
sands of different mRNA targets. They are involved in cellular development, dif-
ferentiation, proliferation, cell division and apoptosis amongst other biological 
processes and they are found entangled with onset and progression of cancer 
and other diseases. 
In the brain, spatial and temporal expression of miRNAs in the nervous sys-
tem hint that regulation of them might be of significance to neuronal develop-
ment and function. The expression of these ncRNAs is dependent on various 
factors and can be kept in check by DNA methylation and chromatin structure, 
other epigenetic mediators [8]. 
3.4. Epigenetic Influence on Psychiatric Disorders 
Genetics is thought to be the originator of psychiatric disorders but currently 
specific gene mutations have yet to be identified as inducers to psychiatric dis-
order development. On the other hand, copious research gives evidence towards 
the epigenetic involvement in pathogenesis of major psychiatric disorders, both 
hypo- and hyper-methylation. 
A grand-scale complete methylome (set of methylation modification of nu-
cleic acids in genome) analysis has brought to the surface global patterns of 
normal brain methylome, schizophrenia-patient and depression-patient brain 
methylomes. Methylome DB (Diabetic Retinopathy) was first to provide a com-
prehensive source of brain methylome data encompassing DNA methylation 
profiling of the whole human genome in addition to schizophrenia and depres-
sion methylome investigations [12]. 
What’s more, histone lysine methylation alterations have demonstrated con-
tributions to modifications in brain transcriptomes, affecting mood and psycho-
sis spectrum disorders (such as depression and schizophrenia). In recent studies, 
miRNAs have also been suggested as having roles in psychiatric pathologies. The 
studies exhibited significantly altered miRNA patterns in the prefrontal cortex of 
schizophrenic and bipolar patients. 
Hence, epigenetic changes are now thought to be the chief regulators of stan-
dard brain development and function and thus also significant influences in a 
large spectrum of neurological and psychiatric disorders. This information 
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makes epigenetic alterations at the centre of the study of future psychiatric 
therapies [8]. 
4. Depression 
4.1. A Basic Overview 
Clinical depression is a serious psychiatric disorder that is characterised by a vast 
array of symptoms that may not all be present within an individual. It can affect 
how a person thinks, feels, acts, the person’s sleep patterns, eating or working. 
There are various types of depression including: 
o Persistent depressive disorder 
o Postpartum depression 
o Psychotic depression 
o Seasonal affective disorder 
o Major depressive disorder—which is mainly what is going to be discussed 
o Bipolar disorder—this doesn’t indicate that it is a type of depression but a 
person with bipolar disorder can experience extreme lows with symptoms 
that meet the criteria for major depression. 
o Disruptive mood dysregulation disorder 
o And premenstrual dysphoric disorder. 
[28] [29] [30] 
For diagnosis of depression the patient must be experiencing the associated 
symptoms for at least 2 weeks. Symptoms that a patient can normally present 
with are: 
o Persistent sadness, anxiety or feeling emptiness 
o Hopelessness or pessimism 
o Increased irritability 
o Feelings of guilt, worthlessness or helplessness 
o Reduced energy or fatigue 
o Slowed down movement or talking 
o Restlessness 
o Concentration or memory issues 
o Indecisiveness 
o Sleep irregularities—early-morning rising or oversleeping 
o Appetite or weight changes 
o Suicidal thoughts or attempts 
o And pain—headaches, cramps or digestive issues that don’t seem to have a 
cause or don’t clear up after treatment. 
[28] [31] [32] 
4.2. Risk Factors 
Depression is caused by an amalgamation of genetic, biological, environmental 
and psychological factors. Epigenetic being one such determinant of depression. 
Depression can occur at any age but it is more often in adulthood. Experience of 
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high anxiety as a child, early-life stress (ELS), can start up a chronic mood and 
anxiety disorder in adulthood. However, depression may still present in children 
and teens, though presentation of irritability is more noticeable rather than a low 
mood [33] [34]. 
Certain serious illnesses much like Parkinson’s disease and cancer can bring 
with them depression by their very nature. On presentation of depression, the 
effects of these diseases on the patient are often worsened. 
A personal or familial history of depression will increase the likelihood of ob-
taining depression as well as drastic life changes, trauma and stress. Along with 
certain illness, some medications can increase the probability of developing de-
pression [28] [31] [32]. 
Other medically related risk factors include: 
o Being female 
o Side effects 
o Premenstrual hormone level changes 
o Suffering from a long-term or serious illness—Stroke, vitamin B12 deficiency, 
hypothyroidism, hepatitis, HIV and some cancers 
o Having another psychiatric disorder 
o Alcohol or drug withdrawal. 
Risk factors related to lifestyle or life events: 
o Being a more sensitive, emotional and anxious person 
o Adverse childhood experiences such as abuse or lack of care 
o Living in poverty and in correlation having a poor education and social dis-
advantage 
o Recent negative events such as being a victim of crime or abuse, experiencing 
a death of a close relation or being newly separated or divorced. 
o Lack of a close confiding relationship 
o Having a baby 
o Alcohol or drug intoxication 
o Lack of bright light exposure, especially sunlight in the winter months. [35] 
4.3. Treatment and Therapy 
Depression is a treatable condition, in even the worst-off cases. That said, the 
earlier a patient starts the treatment, the greater its effect. Normal first-line 
treatment in depression is psychotherapy and then medication or a combination 
of the two. If a reduction of symptoms is not observed, electroconvulsive therapy 
(ECT) amid other brain stimulation therapies may be considered. 
In line with professional help, lifestyle changes such as regular exercise has 
been shown very effective in the recovery processes, however, only in conjunc-
tion to professional help [35]. 
4.3.1. Psychotherapy 
Psychotherapy also referred to as talk therapy is basically an ongoing discussion 
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between the patient and psychiatrist. Per the type of depression a patient pre-
sents with, a specific psychotherapeutic approach is taken. Such evidence-based 
approaches are cognitive-behavioural therapy (CBT), interpersonal therapy 
(IPT) and problem solving therapy [28] [31] [32]. 
4.3.2. Medications 
Antidepressants are the main form of medication used to treat depression. They 
have been found very effective with adults who have moderate to severe depres-
sion as they can help improve how the brain uses its neurotransmitters that ef-
fect mood or stress. There is an extensive lection of anti-depressants available 
and a patient may need to try out various types to find the most effective one for 
them with the least cumbersome side effects. If one has been diagnosed with de-
pression before or a close relative has, the medication used then is a top consid-
eration [28] [31] [32] [35]. 
Medication takes about 2 to 4 weeks for the patient to start experiencing alle-
viation of symptoms. Certain symptoms such as sleep, appetite and concentra-
tion problems improve before any changes in mood occur. Thus, time should be 
allowed before reaching a conclusion on the effectiveness of the therapy pro-
vided. As the patient’s condition progressively improves, the patient with the 
approval and guidance of a medical professional can slowly wean the patient off 
the drug until sides of depression alleviate and stopping medication altogether 
would be the likely course of action in the management of the patient.  
Antipsychotic medication is usually used for treatment of bipolar disorder, 
nevertheless it can sometimes be used against severe depression in combination 
with antidepressants when other forms of treatment haven’t taken effect [35]. 
It is important to note that suicidal thoughts and attempts can increase during 
the first few weeks of therapy for children, adolescents and adults under 25. 
Hence, especially when first starting medication extra care should be taken by 
the professional to ensure safety of patient [28] [31] [32]. 
4.3.3. Brain Stimulation Therapies 
ECT has been proven effective for people with severe depression who didn’t re-
spond well to other treatment options. It is the most acutely effective treatment 
for people with severe depression. Nevertheless, it has been seen to have adverse 
effects on the patient, such as confusion, disorientation and memory loss. The 
side effects are in the most part short-term however can linger especially in the 
months following the treatment. ECT may also be used as a first-line interven-
tion in extreme cases where rapid intervention is required or use of medication 
is not advisable or safe. The procedure can be performed on an outpatient basis 
and constitutes a series of sessions usually along a 2 to 4 week period, 3 times a 
week. The patient is anaesthetised before the ECT begins, even though treatment 
is not painful and the patient doesn’t not feel the electrical impulses. Hence, the 
term electroconvulsive is no longer accurate since an anaesthetised patient does 
not convulse. Figure 6 is portraying a typical ECT session [28] [31] [32] [35]. 
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Transcranial magnetic stimulation (TMS) is also considered when no other 
treatment has proven effective. The procedure involves holding a potent magnet 
over the scalp to stimulate some areas of the brain. The below illustration, Fig-
ure 7, demonstrates TMS [28] [31] [32] [35]. 
 
 
Figure 6. Typical set-up of an ECT session [36]. 
 
 
Figure 7. Image illustrating the induction of electrical currents in the brain (black 
arrows) through the magnetic pulses (red/pink) applied by means of the coil [37]. 
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5. Depression Epigenetics 
5.1. Risk Factors 
The heritability of major depressive disorder (MDD) is around 31% - 42% yet 
research has failed to show evidence of gene loci that contribute to the disorder. 
In addition, a high discrepancy of 50% between identical twins is suggestive of 
factors other than genetic ones contribute to the disorder. 
Environmental stressors have been brought to light as risk factors with still 
varying susceptibility to the environmental stimuli from one individual to an-
other. As MDD cannot be accredited to a specific gene mutation or exposure to a 
specific environmental cause, the theory that MDD arises from alterations in the 
genome brought about by external factors is favoured greatly. 
Epigenetics is therefore, a major possible mechanism by which environmental 
stimuli such as stressors can have persisting modifications in gene expression. In 
rodent models, gene expression alterations have been reported following expo-
sure to acute stress, chronic stress, fear conditioning and post-traumatic stress 
disorder. Furthermore, epigenetic modifications brought on by ELS show that 
emphasis should be made on the epigenetic mechanisms related to the patho-
genesis of MDD in humans. Evidence supports the indication that negative 
stimuli presented early in life can affect behaviour in adulthood and conse-
quently, predispose individuals to mental illnesses such as depression amongst 
susceptibility to other health problems [38]. 
Early Life Stress 
DNA methylation and histone modification at the promoter sites on genes, for 
example brain derived neurotrophic factor (BDNF) which promotes neurogene-
sis, and miRNA expression pattern changes have been seen after prenatal, peri-
natal and postnatal stress. 
DNA methylation pattern changes involved in depression include: 
o BDNF 
o Glucocorticoid receptor 
o And serotonin transporter. 
These have been found prevalent in children who were prenatally exposed to 
stressors from mother such as smoking, depression and stress from abusive 
partnership or war. Negative experiences in early childhood like being a victim 
of child abuse show that the epigenetic influences (such as methylation) on the 
glucocorticoid receptor and the rRNA promoter were altered—through investi-
gation of the post-mortem brains of suicide victims with experience of abuse as 
children. What’s more, early life poverty and low socioeconomic status show a 
DNA methylation. 
The exposure to a mix of various pre- and post-natal stressful stimuli is asso-
ciated with epigenetic alterations to depression related gene loci in rodents and 
also in humans. These epigenetic modifications are why ELS may take long-term 
effects on a person and their offspring—even though they themselves have not 
experienced the trauma, meaning also they can be further passed on to more 
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generations down the line. Transgenerational phenotypic transmission is under-
lined by environmentally produced stable, persistent epigenetic changes in gene 
expression [34] [38] [39]. 
1) BDNF 
Methylmercury exposure during gestation shows increased depressive-like 
behaviour in mice. The exposed mice had a decreased hippocampal mRNA of 
the BDNF through increased methylation and decreased histone acetylation of 
BDNF gene promotor region. Postnatal stressors, such as lack of or reduced ma-
ternal care, give rise to decreased BDNF transcription in prefrontal cortex which 
was followed up by increased suppression of BDNF promoter site in adulthood 
because of higher DNA methylation levels. This effect was found to be reversible 
by the administration of a DNA methyltransferase inhibitor, zebularine. Figure 8 






Figure 8. A pup grows up to be anxious or relaxed depends on the mother that raises it 
not the one that gave birth to it (a). Proof of methylation effect on behaviour through 
epigenomic change rather than genomic (right) [42]. 
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5.2. MDD 
Depression-related genes, for instances GABA receptor subunits, serotonin 
transporter, mRNA expression of epigenetically involved enzymes and synapsins 
have been studied along with genome-wide DNA methylation patterns in MDD 
patients. Certain importance has been placed on BDNF pathway due to its ob-
served epigenetic modification in MDD. 
BDNF promoter methylation i.e. decreased BDNF mRNA levels in Wernicke’s 
area was discovered in suicide victims a portion of whom were diagnosed with 
MDD. However, DNA methylation and mRNA expression of the BDNF recep-
tor, Trk B, in Wernicke’s area was not found to be modified. Instead, the recep-
tor was found in decreased levels within the prefrontal cortex in relation to in-
creased CpG site and histone 3 methylation at Trk B promoter region. 
Evidence also indicates that miRNA regulation of proteins in MDD patients 
was decreased and reorganised in comparison to control individuals. Changes 
in; miRNA levels; polymorphisms in miRNAs and their precursors; the miRNA 
targeted mRNA; and in the miRNA biogenesis regulator genes are observed in 
MDD. 
DNA methylation, histone alteration and miRNA expression changes are 
greatly involved in the disruption and dysregulation of gene expression in de-
pression. Better understanding of the mechanisms of depression pathogenesis 
opens doors to improved diagnosis and specific targeted treatment [38] [43]. 
5.3. Treatment and Therapy 
5.3.1. Medications 
Regardless of epigenetics’ role in depression pathogenesis, epigenetic alterations 
of gene expression aid in the mechanisms antidepressant medication action. 
Changes in DNA methylation, miRNA activity and chromatin activation status 
were observed when comparing the data of before and after antidepressant ad-
ministration preclinical and clinical investigations. 
A particular study showed that antidepressant treatment of social defeat stress 
in mice (its symptoms mimic depressive symptoms in humans) with imipramine, 
results in increased mRNA levels for BDNF which were previously reduced on 
presentation of the disorder. 
Collectively, the data from human and animal models put forth the suggestion 
that antidepressant treatment reverses the alterations to the epigenome or in-
troduces alternative compensatory epigenetic mechanisms (e.g. histone hyper-
acetylation and DNA hypomethylation) which promote expression of previously 
repressed genes. 
Garnering a more holistic understanding of epigenetic action in antidepres-
sant mechanisms may direct development of novel MDD treatments, such as 
targeted HDAC inhibitors, DNA methyltransferase inhibitors and miRNA inhi-
bition with small molecules. More so, expression patterns of miRNA can possi-
bly serve as valuable biomarkers in prediction of the individual’s response to 
treatment [38] [40] [44]. 
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5.3.2. Brain Stimulation Therapies 
The precise mode of action of ECT is unknown, however, evidence points to-
wards the mechanisms of epigenetic modification of gene expression. Examined 
changes in rat hippocampal BDNF at different time intervals during electrocon-
vulsive stimulation (ECS—the animal equivalent of ECT) indicate that the re-
sulting histone modifications on BDNF gene expression depend on treatment 
duration, post-treatment time and the gene promoter region. Histone modifica-
tion and related mRNA alterations of CREB (cAMP response element binding 
protein) and c-Fos (a proto-oncogene expressed in some neurons following de-
polarisation) as well as elevated DNA methylation at the Arc promoter also re-
sult from the use of ECS in the animal model. 
These findings strengthen the idea that epigenetic changes of gene expression 
have a key role in the action of ECT as a powerful form of anti-depressant 
treatment, even though human model testing has yet to be investigated [38] [39] 
[44] [45]. 
6. Conclusions 
It is safe to say that epigenetics requires more time and research dedicated to it. 
Epigenetics is a word that spans a great number of concepts, mechanisms and 
theories. In this paper, only the tip of the tip of the iceberg that is epigenetics has 
been discussed. Attention has been brought to the fact that each mechanism of 
epigenetics is affected by different stimuli and affects different aspects of the ge-
netic material. Disruption in the balance between HAT proteins and HDAC 
proteins mediating histone acetylation and deacetylation can result in neurode-
generative diseases. Each mechanism has a basic effect on the genome, for ex-
ample, DNA methylation inactivates a gene’s expression and demethylation re-
verses this. 
Our surroundings are major contributors to our epigenetic differences. Dif-
ferent stimuli result in diverging epigenetic modifications which can be stable 
and persistent for an entire lifetime. However, the modifications are reversible 
through exposure to other stimuli or through specific epigenetic targeting drugs. 
Increased depressive behaviour due to methylmercury exposure in mice is re-
versible by a DNA methyltransferase inhibitor. Moreover, even though repro-
gramming occurs at gametogenesis to remove parental epigenetics, transgenera-
tional epigenetic contributions may still occur, causing a transference of an “an-
cestral memory” which can affect anything including behaviour and vulnerabil-
ity to physical and mental health problems. 
Over and above this, epigenetics with respect to depression is reviewed. 
Imipramine administration to mice with social defeat stress increases the previ-
ously reduced mRNA levels for BDNF. Human models on the topic are few and 
far in between but those that are available confirm many of the animal models 
and the speculations on their application to the human epigenetic mechanisms. 
Through the animal and human studies, theories on new antidepressant thera-
peutics are being investigated and the promise of more specific and effective 
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medication is over the horizon. The epigenetic rabbit hole is a dark and vast 
space which has yet to be brought to light and its walls have yet to be reached. 
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